Blackhawk Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,521	Closed	-$1.61M	–	140
2025 Q1	$1.61M	Buy	14,521 +4,750	+49%	+$525K	0.83%	38
2024 Q4	$1.33M	Buy	+9,771	New	+$1.33M	0.69%	54